Treatment of Lesions With a High Risk of Stenosis. Comparative Study in 300 Patients of Rapamycin-and Paclitaxel-Eluting Polymer-Based Stents, and Bare Metal Stents
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 58 (3) , 262-269
- https://doi.org/10.1016/s1885-5857(06)60487-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary $beta;-radiation therapyPublished by Oxford University Press (OUP) ,2004
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)The Lancet, 2003
- TAXUS III TrialCirculation, 2003
- Sirolimus-eluting stent for treatment of complex in-stent restenosisJournal of the American College of Cardiology, 2003
- TAXUS ICirculation, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001